ALERS Eurobio Scientific Société anonyme

28.96USD26.40 EUR · EPA0.00%Mkt Cap: 291.53M USDP/E: 37.71

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The compan…

Institutional holders4 on file

Key Statistics

Company
Market Cap291.53M USD
Enterprise Value278.81M USD
Revenue (TTM)188.93M USD
Gross Profit84.28M USD
Net Income (TTM)5.34M USD
Revenue/Share18.43 USD
Last Price28.96 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees443
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0013240934
Valuation
P/E (Trailing)37.71
P/E (Forward)23.36
PEG—
EV/EBITDA11.16
EV/Revenue1.48
P/S1.54
P/B1.39
EPS (TTM)0.77 USD
EPS (Forward)1.24 USD
52W Range
21.0698% of range29.12
52W High29.12 USD
52W Low21.06 USD
Profitability
Gross Margin45.58%
Oper. Margin7.75%
EBITDA Margin13.23%
Profit Margin2.89%
ROE2.65%
ROA1.89%
ROIC3.73%
ROCE5.10%
Growth
Revenue Growth4.50%
Earnings Growth99.00%
Cash Flow & Leverage
Operating CF20.68M USD
CapEx (TTM)13.79M USD
FCF Margin-7.42%
FCF Yield-4.81%
Net Debt-12.72M USD
Net Debt/EBITDA-0.51
Net Debt/FCF—
Balance Sheet
Debt/Equity0.09
Current Ratio3.16
Quick Ratio1.84
Book Value/Sh20.85 USD
Cash/Share2.87 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 1, 2017
Analyst Consensus
Rating—
Target (Mean)32.90 USD
Upside (mean)+13.6%
Target Range32.90 USD – 32.90 USD
# Analysts1
Ownership
Shares Out.10.07M
Float843.62K
Insiders0.00%
Institutions91.12%
Technical
SMA 5027.50 (+5.3%)
SMA 20024.97 (+16.0%)
Beta0.67
S&P 52W Chg12.00%
Avg Vol (30d)1.48K
Avg Vol (10d)926
Technical Indicators
RSI (14)74.7
MACD0.3866
MACD Signal0.4744
MACD Hist.-0.0878
BB Upper29.56 USD
BB Middle28.80 USD
BB Lower28.04 USD
BB Width5.30%
ATR (14)0.1991 USD
Vol Ratio (20d)0.85x

About Eurobio Scientific (EPA: ALERS)

›

Eurobio Scientific (EPA: ALERS) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 443 employees.

The shares were at 26.40 EUR on 19 November 2026, up 8.2% over 52 weeks. Its 52-week range is 19.20 EUR to 26.55 EUR, and it trades at the top of that range.

At a market capitalisation of 265.80M EUR, it trades at 37.7 times trailing earnings and 23.4 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 47% for ALERS.

Eurobio Scientific reports return on equity of 2.6%, an operating margin of 7.8% and revenue up 4.5% year over year.

It holds more cash than debt, a net cash position of 11.60M EUR. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 30.00 EUR is 13.6% above the current price.